The Valley Desk

NCT05159778 · Interventional trial

Phase 2 Study of Imprime PGG and Pembrolizumab in Patients With HR+/HER2- Metastatic Breast Cancer (mBCA)

Overall registry status Completed

Phase 2

Conditions Malignant Neoplasm of Breast

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov